A study conducted by Dal et.al [48] on CEA, CYFRA 21-1 and NSE levels in patients with advanced NSLC (54 out of 70 patients presented with adenocarcinoma) found no significant modifications in NSE serum levels after chemotherapy treatment [48]. This evidence concerns the gene ENO2 and adenocarcinoma.